Janssen PMP and Lipofabrik signed a global collaboration agreement to develop Mycosubtilin containing products

Date:03-11-2021

Janssen PMP, a division of Janssen Pharmaceutica NV, announced the signature of a collaboration agreement with the French company Lipofabrik SAS specialized in the production, purification, formulation and marketing of lipopeptides. Janssen PMP will develop products containing Mycosubtilin, a patented lipopeptide from Lipofabrik SAS, to preserve fresh produce quality in the global market.

Janssen PMP will develop for Post-Harvest, specific and fit-for-purpose formulations containing lipopeptides including Mycosubtilin. Preliminary trials showed a very strong activity of this natural compound allowing for extension of shelf life of harvested produce.

“Signing this agreement is the beginning of a major strategic collaboration between our respective companies which will benefit the whole fruit industry” says Joan Jørgensen, General Manager of Janssen PMP. “The market is demanding efficient, natural solutions that can prevent the degradation and extend the shelf life of fruit”.

“Lipofabrik will benefit from this close collaboration with Janssen PMP on technical, regulatory and commercial aspects” says Arnaud Delecroix, CEO of Lipofabrik SAS. “This agreement will contribute to bringing Lipofabrik to a next level in terms of business development”.